BioSpace News Archive

Business

Hazelden Betty Ford to Honor Oregon Recovery Leader and Nationally Recognized Innovator Brent Canode

Third-annual “Kelly Clark Spirit Award” to be presented May 17 in memory of the generous, loving legacy of the late Portland attorney Kelly Clark

March 20, 2019
·
5 min read
Psychiatry UK and Digital Health Startup, Taliaz, Launch New Online Service to Deliver Groundbreaking Artificial Intelligence-Genetic Testing to Depression Sufferers

Online medically-managed Predictix genetic testing service aims to reduce patient suffering by helping psychiatrists personalize antidepressant medication sooner

March 20, 2019
·
2 min read
Business

BioMed Realty Launches The Second Phase At Gateway of Pacific - Expanding Its Landmark Campus At The Front Door Of San Francisco’s Premier Life Science Market

BioMed Realty also closes a $430 million financing on the first phase of Gateway of Pacific after executing a long-term lease with AbbVie Inc. for 480,000 square feet

March 20, 2019
·
3 min read
Biotech Beach

Pets: Most common medical conditions that prompt veterinary visits

Nationwide members spent $119 million to treat the top 10 medical conditions affecting dogs and cats

March 20, 2019
·
3 min read
BioMidwest

Washington, Michigan and Wisconsin See Flu Activity Gains

Walgreens Flu Index for week ending March 16, 2019

March 20, 2019
·
3 min read
Deals

Fishawack continues to build best-in-class service offering with Dudnyk acquisition

They leverage strategic, scientific, and creative capabilities to serve clients in the biotech, pharmaceutical, and medical device industries.

March 20, 2019
·
4 min read
Job Trends

Magellan Health Provides Free Counseling Services and Referrals to Local Community Resources to Individuals Impacted by Floods in Nebraska

Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will open a free 24-hour crisis line for all individuals impacted by the flooding in Nebraska.

March 20, 2019
·
1 min read
Pharm Country

Novo Nordisk files for US FDA approval of oral semaglutide for blood sugar control and cardiovascular risk reduction in adults with type 2 diabetes

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the US Food and Drug Administration (FDA) for oral semaglutide, the first once-daily glucagon-like peptide-1 (GLP-1) receptor agonist in a pill

March 20, 2019
·
9 min read
Job Trends

Canary Speech Announces New Patent for Its Technology in Using Voice to Detect Medical Conditions

Canary Speech, a speech and language company known for its novel approach to identifying disease and human conditions through the creation of mathematical models to rapidly and accurately identify biomarkers from a limited vocal sample, announced today that the U.S. Patent and Trademark Office has granted to Canary Speech a patent for broader claims for its inventions.

March 20, 2019
·
2 min read
BioCapital

CAQH CORE Awards More than 350 Certifications, Demonstrating Industry Progress Toward Automation, Interoperability and Administrative Efficiency

CAQH CORE has awarded more than 350 certifications to healthcare organizations that conform to CAQH CORE Operating Rules.

March 20, 2019
·
3 min read